Published

ChemInform Abstract: CRYSTAL STRUCTURES OF THE TEONANACATL HALLUCINOGENS PART1, PSILOCYBIN C12H17N2O4O

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: ChemInform
Date: 1974-09-03
Source: OpenAlex
DOI: 10.1002/chin.197435062
PubMed: Unavailable

Authors

Hans Peter Weber Trevor J. Petcher

Watch author

Derived topics and classifications

psilocybin Receptor Pharmacology Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

ChemInform Abstract: CRYSTAL STRUCTURES OF THE TEONANACATL HALLUCINOGENS PART1, PSILOCYBIN C12H17N2O4O1974-09-03

Related papers

Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case ReviewMexican Journal of Medical Research ICSA · 2026-07-05 Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive UseJournal of Advances in Developmental Research · 2026-06-17 From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10 The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant DepressionEmerging Minds Journal for Student Research · 2026-01-25 A Systematic Review of EEG Predictors and Correlates of Psilocybin’s Treatment in DepressionUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2026-07-27 Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USAAJPM Focus · 2026-05-01 Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).Professional Psychology Research and Practice · 2026-02-01 COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDERGenetics and Molecular Research · 2026-01-01